This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (11)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Experimental and Clinical Investigations

G. B. BIETTI, M.D.

Arch Ophthal. 1950;43(3):431-445.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

OF THE substances recently proposed for the chemotherapy of of tuberculosis, only sulfones and streptomycin have received attention from ophthalmologists, while information is still lacking on the most recent discovery in this field, paraaminosalicylic acid, already recognized as valuable in treatment of extraocular tuberculosis. The Tb 1/698 of Domagk (a thiosemicarbazone preparation) and the "asiaticoside" (derived by Boiteau from the plant Hydrocotyle asiatica) are still awaiting a more complete trial of their antituberculosis properties.¹

It would take too much space to report here what has already been done with sulfones and streptomycin in experimental ocular tuberculosis, and it seems hardly necessary to recall the outstanding contributions published in the United States by Steenken and his associates, and in particular by Alan Woods and his collaborators.

They proved that sulfones (promin^® [N, N'-didextrose sulfonate, the sodium salt of P,P'-diaminodiphenyl sulfone]) and promizole^® [4,2'-diaminophenyl-5'-thiazolylsulfone] ) exert a definite deterrent action . . . [Full Text PDF of this Article]

Author Affiliations
Professor of Ophthalmology, University of Pavia PAVIA, ITALY

Footnotes
Read at the Eighty-Fifth Annual Meeting of the American Ophthalmological Society, Hot Springs, Va., June 1949.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?